111in cmd-193
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2006 (NCT00293215)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 111-indium
Oral
No
Parenteral
No
Topical
No
Also known as
- 111in cmd-193
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00293215 | Phase 1 | Feb 1, 2006 | Ludwig Institute for Cancer Research, Wyeth |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ludwig Institute for Cancer Research | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Wyeth | For profit | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1